Adiponectin, an adipokine secreted by adipocytes, exerts favorable effects in the milieu of
diabetes and metabolic syndrome through its anti-inflammatory, antifibrotic, and antioxidant …

Patients with end-stage kidney disease (ESKD) on maintenance hemodialysis are subject to
a high burden of inflammation and cardiovascular disease, driven at least in part by …

Introduction: Cardiovascular diseases are highly prev-alent in patients with chronic kidney
disease (CKD), and represent the major hazard for mortality in this population. Anomalies of …

Chronic kidney disease (CKD) is commonly associated with a high burden of comorbidities
and poor clinical outcomes. Malnutrition–inflammation–atherosclerosis syndrome is …

BACKGROUND: Adiponectin is an anti-inflammatory adipokine that may play a role in
chronic obstructive pulmonary disease (COPD) pathogenesis. OBJECTIVE: To investigate …

Obezite ve obeziteyle birlikte ortaya çıkan hipertansiyon, dislipidemi, diyabet gibi
ateroskleroza yol açan risk faktörleri kardiyovasküler hastalıkların oluşmasına neden …

Background and Objectives Left ventricular mass (LVM) is known to be related to overall and
cardiovascular mortality in end stage kidney disease (ESKD) patients. The aims of the …

Adiponectin and urinary adiponectin excretions have been ascribed a function in glomerular
physiology and seem to indicate vascular disease in diabetes. The aim of this study was to …

BACKGROUND: Protein-energy malnutrition is still a problem in patients with chronic renal
failure, especially during replacement renal therapy. The chronic inflammatory status in …

In patients with chronic renal failure undergoing dialysis the mortality rate from
cardiovascular conditions is 10 to 100 fold than in general population. The higher mortality …